Results 41 to 50 of about 103,219 (202)
Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). [PDF]
INTRODUCTION: Retroperitoneal sarcoma (RPS) is a rare disease accounting for 0.1%-0.2% of all malignancies. Management of RPS is complex and requires multidisciplinary, tailored treatment strategies at all stages, but especially in the context of ...
Rutkowski, Piotr +105 more
core +2 more sources
Extraskeletal osteosarcoma is an uncommon high-grade malignant soft tissue sarcoma. Well-differentiated extraskeletal osteosarcoma is thought to have a better prognosis than classical extraskeletal osteosarcoma, but dedifferentiation after recurrence has
Hiromasa Arai +8 more
doaj +1 more source
Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS) [PDF]
Retroperitoneal sarcoma; Retroperitoneum; Soft tissue sarcomaSarcoma retroperitoneal; Retroperitoneo; Sarcoma de tejidos blandosSarcoma retroperitoneal; Retroperitoneu; Sarcoma dels teixits tousSoft tissue sarcomas (STS) are an uncommon and biologically ...
AGRA PUJOL, CAROLINA +6 more
core +1 more source
Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach
Retroperitoneal sarcomas are a heterogenous group of rare tumors arising in the retroperitoneum. Retroperitoneal sarcomas comprise approximately 10% of all soft tissue sarcomas.
Joon Hyuk Choi, Jae Y. Ro
doaj +1 more source
Delays in the management of retroperitoneal sarcomas. [Elektronisk resurs]
Retroperitoneal sarcomas are rare and treatment should optimally be centralized. Despite successful centralization with 90% of the patients referred prior to surgery, delays occur, which led us to assess lead times in a population-based series.
Rydholm, Anders, +5 more
core +1 more source
Retroperitoneal sarcoma (RPS) is a heterogeneous group of malignant tumors with an incidence of approximately 1 case per 100,000 population per year, which includes leiomyosarcoma.
T. Tajibayev +4 more
doaj +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
A Rare Diagnostic Challenge of Retroperitoneal Unicentric Castleman Disease.
1. Brief medical history. 48-year-old lady post-menopausal lady, medically free, presented to the hospital with fatigue over the last 8 months, she recently felt a mass in her abdomen.
Ghaida Daghistani
doaj +1 more source
ABSTRACT Background Although MDM2 FISH test has been increasingly used to differentiate ALT and benign lipomatous tumours, its impact on clinical outcome remains underexplored. This study investigated whether routine MDM2 FISH testing on preoperative biopsy is associated with a reduction in the recurrence risk of ALT.
Samuel O. H. Ching +5 more
wiley +1 more source
Radiological findings of primary retroperitoneal synovial sarcoma
Synovial sarcomas are most commonly localized in the extremities, especially the lower thigh and knee areas. Retroperitoneal synovial sarcoma is very rare.
Bal, N +5 more
core +1 more source

